FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3042718321> ?p ?o ?g. }

• W3042718321 endingPage "325" @default.
• W3042718321 startingPage "309" @default.
• W3042718321 abstract "PurposeTo compare the effectiveness and safety of platelet-rich plasma (PRP) and hyaluronic acid (HA) in patients with adult knee osteoarthritis (KOA) and to explore the most effective and safe protocol by using a meta-analysis method.MethodsThis study was based on Cochrane methodology for conducting a meta-analysis. Only randomized controlled trials with an experimental group that used PRP and a control group that received HA were eligible for this study. The participants were adults who had KOA. The outcome measures were the Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC), the visual analog scale (VAS), the EuroQol VAS, the International Knee Documentation Committee, the Tegner score, the Lequesne Scale, the Knee injury Osteoarthritis Outcome Score, satisfaction rate, and adverse events. Subgroup analyses was performed for patients with different doses, types, and times of PRP interventions and grades of OA. The Review Manager Database was used to analyze the included studies.ResultsTwenty-six randomized controlled trials involving 2430 patients were included. The WOMAC total scores, WOMAC physical function scores, and VAS scores of the PRP group were better than the those of the HA group at 3, 6, and 12 months. The PRP group had better WOMAC pain, WOMAC stiffness, EuroQol VAS, and International Knee Documentation Committee scores than the HA group at 6 and 12 months. There was no significant difference in adverse events between the 2 groups (relative risk 1.21, 95% confidence interval 0.95-1.54; P = .13).ConclusionsFor the nonsurgical treatment of KOA, compared with HA, intra-articular injection of PRP could significantly reduce patients’ early pain and improve function. There was no significant difference in adverse events between the 2 groups. PRP was more effective than HA in the treatment of KOA, and the safety of these 2 treatment options was comparable.Level of EvidenceLevel I, meta-analysis of Level I RCTs. To compare the effectiveness and safety of platelet-rich plasma (PRP) and hyaluronic acid (HA) in patients with adult knee osteoarthritis (KOA) and to explore the most effective and safe protocol by using a meta-analysis method. This study was based on Cochrane methodology for conducting a meta-analysis. Only randomized controlled trials with an experimental group that used PRP and a control group that received HA were eligible for this study. The participants were adults who had KOA. The outcome measures were the Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC), the visual analog scale (VAS), the EuroQol VAS, the International Knee Documentation Committee, the Tegner score, the Lequesne Scale, the Knee injury Osteoarthritis Outcome Score, satisfaction rate, and adverse events. Subgroup analyses was performed for patients with different doses, types, and times of PRP interventions and grades of OA. The Review Manager Database was used to analyze the included studies. Twenty-six randomized controlled trials involving 2430 patients were included. The WOMAC total scores, WOMAC physical function scores, and VAS scores of the PRP group were better than the those of the HA group at 3, 6, and 12 months. The PRP group had better WOMAC pain, WOMAC stiffness, EuroQol VAS, and International Knee Documentation Committee scores than the HA group at 6 and 12 months. There was no significant difference in adverse events between the 2 groups (relative risk 1.21, 95% confidence interval 0.95-1.54; P = .13). For the nonsurgical treatment of KOA, compared with HA, intra-articular injection of PRP could significantly reduce patients’ early pain and improve function. There was no significant difference in adverse events between the 2 groups. PRP was more effective than HA in the treatment of KOA, and the safety of these 2 treatment options was comparable." @default.
• W3042718321 created "2020-07-23" @default.
• W3042718321 creator A5036309922 @default.
• W3042718321 creator A5052556650 @default.
• W3042718321 creator A5062047261 @default.
• W3042718321 creator A5090275089 @default.
• W3042718321 date "2021-01-01" @default.
• W3042718321 modified "2023-10-16" @default.
• W3042718321 title "Platelet-Rich Plasma Versus Hyaluronic Acid in the Treatment of Knee Osteoarthritis: A Meta-analysis of 26 Randomized Controlled Trials" @default.
• W3042718321 cites W1031259716 @default.
• W3042718321 cites W1728787893 @default.
• W3042718321 cites W1974360558 @default.
• W3042718321 cites W1991070635 @default.
• W3042718321 cites W2009242989 @default.
• W3042718321 cites W2018004536 @default.
• W3042718321 cites W2022893427 @default.
• W3042718321 cites W2067079430 @default.
• W3042718321 cites W2088653124 @default.
• W3042718321 cites W2089973119 @default.
• W3042718321 cites W2100200474 @default.
• W3042718321 cites W2108738802 @default.
• W3042718321 cites W2109675827 @default.
• W3042718321 cites W2111068863 @default.
• W3042718321 cites W2113670619 @default.
• W3042718321 cites W2125605937 @default.
• W3042718321 cites W2132844854 @default.
• W3042718321 cites W2139382287 @default.
• W3042718321 cites W2141157018 @default.
• W3042718321 cites W2143328793 @default.
• W3042718321 cites W2161736885 @default.
• W3042718321 cites W2239757254 @default.
• W3042718321 cites W2253918529 @default.
• W3042718321 cites W2268621357 @default.
• W3042718321 cites W2276644929 @default.
• W3042718321 cites W2286191622 @default.
• W3042718321 cites W2327421967 @default.
• W3042718321 cites W2464119509 @default.
• W3042718321 cites W2535103699 @default.
• W3042718321 cites W2560541879 @default.
• W3042718321 cites W2563112167 @default.
• W3042718321 cites W2582012588 @default.
• W3042718321 cites W2588369972 @default.
• W3042718321 cites W2599365661 @default.
• W3042718321 cites W2743372773 @default.
• W3042718321 cites W2761873219 @default.
• W3042718321 cites W2782195511 @default.
• W3042718321 cites W2784772121 @default.
• W3042718321 cites W2789619168 @default.
• W3042718321 cites W2790600717 @default.
• W3042718321 cites W2794579873 @default.
• W3042718321 cites W2807477579 @default.
• W3042718321 cites W2808837648 @default.
• W3042718321 cites W2896243120 @default.
• W3042718321 cites W2905199157 @default.
• W3042718321 cites W2907286282 @default.
• W3042718321 cites W2910732653 @default.
• W3042718321 cites W2921265821 @default.
• W3042718321 cites W2973761577 @default.
• W3042718321 cites W307923840 @default.
• W3042718321 cites W4253649408 @default.
• W3042718321 doi "https://doi.org/10.1016/j.arthro.2020.07.011" @default.
• W3042718321 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32679294" @default.
• W3042718321 hasPublicationYear "2021" @default.
• W3042718321 type Work @default.
• W3042718321 sameAs 3042718321 @default.
• W3042718321 citedByCount "39" @default.
• W3042718321 countsByYear W30427183212020 @default.
• W3042718321 countsByYear W30427183212021 @default.
• W3042718321 countsByYear W30427183212022 @default.
• W3042718321 countsByYear W30427183212023 @default.
• W3042718321 crossrefType "journal-article" @default.
• W3042718321 hasAuthorship W3042718321A5036309922 @default.
• W3042718321 hasAuthorship W3042718321A5052556650 @default.
• W3042718321 hasAuthorship W3042718321A5062047261 @default.
• W3042718321 hasAuthorship W3042718321A5090275089 @default.
• W3042718321 hasBestOaLocation W30427183211 @default.
• W3042718321 hasConcept C126322002 @default.
• W3042718321 hasConcept C14184104 @default.
• W3042718321 hasConcept C142724271 @default.
• W3042718321 hasConcept C168563851 @default.
• W3042718321 hasConcept C1862650 @default.
• W3042718321 hasConcept C187960798 @default.
• W3042718321 hasConcept C197934379 @default.
• W3042718321 hasConcept C204787440 @default.
• W3042718321 hasConcept C2776164576 @default.
• W3042718321 hasConcept C2776478404 @default.
• W3042718321 hasConcept C2779286237 @default.
• W3042718321 hasConcept C2780076745 @default.
• W3042718321 hasConcept C44249647 @default.
• W3042718321 hasConcept C71924100 @default.
• W3042718321 hasConcept C89560881 @default.
• W3042718321 hasConcept C95190672 @default.
• W3042718321 hasConceptScore W3042718321C126322002 @default.
• W3042718321 hasConceptScore W3042718321C14184104 @default.
• W3042718321 hasConceptScore W3042718321C142724271 @default.
• W3042718321 hasConceptScore W3042718321C168563851 @default.
• W3042718321 hasConceptScore W3042718321C1862650 @default.
• W3042718321 hasConceptScore W3042718321C187960798 @default.

• next